Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crestor for Prevention of Colon Polyps and Cancer Recurrence
NCT01011478Phase 3Terminated
- Sponsor
- NSABP Foundation
- Start
- Mar 2010
- Primary completion
- Dec 2014
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of rosuvastatin in colorectal cancer (CRC) and adenomatous polyp, sponsored by NSABP Foundation. Started Mar 2010; status: terminated.
02
Drugs
rosuvastatin
03
Conditions
colorectal cancer (CRC)adenomatous polyp
Beyond the preview
Go deeper on NCT01011478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011478.